Lisa E. Hines
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Lisa E. Hines has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Daniel C. Malone
Department of Pharmacotherapy College of Pharmacy, University of Utah Salt Lake City Utah USA
2 shared publications Austin Gessay
Walgreens Pharmacy, Phoenix, Arizona
1 shared publication- Bimal V. Patel
MedImpact Healthcare Systems, Inc., San Diego, California, USA
1 shared publication Duane Sherrill
Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona
1 shared publication- Edward P. Armstrong
University of Arizona College of Pharmacy, Tucson, AZ 85721, USA
1 shared publication J. Michael Menke
Patient Reported Outcome (PRO) Consortium, Critical Path Institute, Tucson, Arizona
1 shared publication
Latest Publications
- Open Access
- 4 March 2013
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 13 (1) , 32
Evaluation of a drug-drug interaction: fax alert intervention program
Clinicians often encounter information about drug-drug interactions (DDIs) during clinical practice. This information is found within product information (hardcopy and electronic) and various electronic systems. Prescribers may receive medication-related communications in practice that are distributed by facsimile (fax), mail, or telephone from pharmacies and pharmacy benefit managers (PBMs). The purpose of this study was to determine if near-real time fax alerts for potential drug-drug interactions (PDDIs) would influence prescribing.
- 4 March 2013
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 13 (1) , 32
Open AccessEvaluation of a drug-drug interaction: fax alert intervention program
Clinicians often encounter information about drug-drug interactions (DDIs) during clinical practice. This information is found within product information (hardcopy and electronic) and various electronic systems. Prescribers may receive medication-related communications in practice that are distributed by facsimile (fax), mail, or telephone from pharmacies and pharmacy benefit managers (PBMs). The purpose of this study was to determine if near-real time fax alerts for potential drug-drug interactions (PDDIs) would influence prescribing.
- 1 December 2011
- Published by Elsevier in The American Journal of Geriatric Pharmacotherapy
- Vol. 9 (6) , 364-377
Potentially Harmful Drug–Drug Interactions in the Elderly: A Review
- 1 December 2011
- Published by Elsevier in The American Journal of Geriatric Pharmacotherapy
- Vol. 9 (6) , 364-377
Potentially Harmful Drug–Drug Interactions in the Elderly: A Review
- 28 March 2011
- Published by Wiley in Journal of the American Academy of Nurse Practitioners
- Vol. 23 (4) , 216-221
Medical, nursing, and pharmacy students’ ability to recognize potential drug-drug interactions: A comparison of healthcare professional students
To evaluate and compare the drug-drug interaction (DDI) knowledge of pharmacy, medical, and nurse practitioner (NP) students who are beginning supervised clinical practice. This study utilized a prospective evaluation of DDI knowledge among healthcare professional students who were currently enrolled in their final didactic year at the University of Arizona Colleges of Medicine, Pharmacy, or Nursing's NP program. Students were asked to assess 15 drug pairs and to select an appropriate management strategy for each pair. The primary outcome measure was the ability to correctly categorize each drug pair into one of the five management responses. The secondary outcome measure was the number of clinically significant DDIs recognized. Pharmacy students demonstrated significantly better knowledge than medical and NP students with respect to identifying and selecting management strategies for possible DDIs. However, there is much room for improvement for all groups. An increase in curricular content that focuses on DDIs has the potential to better prepare medical, pharmacy, and NP students for practice situations involving DDI alerts, and to increase the quality of patient care.
- 28 March 2011
- Published by Wiley in Journal of the American Academy of Nurse Practitioners
- Vol. 23 (4) , 216-221
Medical, nursing, and pharmacy students’ ability to recognize potential drug-drug interactions: A comparison of healthcare professional students
To evaluate and compare the drug-drug interaction (DDI) knowledge of pharmacy, medical, and nurse practitioner (NP) students who are beginning supervised clinical practice. This study utilized a prospective evaluation of DDI knowledge among healthcare professional students who were currently enrolled in their final didactic year at the University of Arizona Colleges of Medicine, Pharmacy, or Nursing's NP program. Students were asked to assess 15 drug pairs and to select an appropriate management strategy for each pair. The primary outcome measure was the ability to correctly categorize each drug pair into one of the five management responses. The secondary outcome measure was the number of clinically significant DDIs recognized. Pharmacy students demonstrated significantly better knowledge than medical and NP students with respect to identifying and selecting management strategies for possible DDIs. However, there is much room for improvement for all groups. An increase in curricular content that focuses on DDIs has the potential to better prepare medical, pharmacy, and NP students for practice situations involving DDI alerts, and to increase the quality of patient care.